Zouboulis, Christos C, Martin M Okun, Robert Gniadecki, Peter A Foley, Charles Lynde, Jamie Weisman, Piyalal Karunaratne, and David A Williams. “Adalimumab Efficacy in Hidradenitis Suppurativa Patients Is Sustained at Least Three Years With Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER)”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s128. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/81.